Projects funded by the NCN


Information on the principal investigator and host institution

Information of the project and the call

Keywords

Equipment

Delete all

The study of mechanisms that enhance the antitumor activity of 5-FU by the use of vitamin D analogs in human colon cancer model

2012/05/N/NZ5/00883

Keywords:

vitamin D analogs 5-fluorouracil colon cancer combined treatment anticancer therapy

Descriptors:

  • NZ5_7: Human disease treatment

Panel:

NZ5 - Human and animal noninfectious diseases: etiology, mechanisms, diagnosis and treatment of diseases, poisonings and injuries (without neurological diseases)

Host institution :

Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda PAN

woj. dolnośląskie

Other projects carried out by the institution 

Principal investigator (from the host institution):

dr Magdalena Milczarek 

Number of co-investigators in the project: 2

Call: PRELUDIUM 3 - announced on 2012-03-15

Amount awarded: 150 000 PLN

Project start date (Y-m-d): 2013-01-31

Project end date (Y-m-d): 2016-09-30

Project duration:: 44 months (the same as in the proposal)

Project status: Project settled

Information in the final report

  • Publication in academic press/journals (2)
  • Articles in post-conference publications (2)
  1. Tacalcitol increases the sensitivity of colorectal cancer cells to 5-fluorouracil by down-regulation of thymidylate synthase
    Authors:
    Magdalena Milczarek, Joanna Rossowska, Dagmara Kłopotowska, Martyna Stachowicz, Andrzej Kutner, Joanna Wietrzyk
    Academic press:
    Molecular Cancer (rok: 2018, tom: -, strony: -), Wydawca: BMC
    Status:
    Submitted
  2. Vitamin D analogs combined with 5-fluorouracil in human HT-29 colon cancer treatment
    Authors:
    Magdalena Milczarek, Beata Filip-Psurska, Wiesław Świętnicki, Andrzej Kutner, Joanna Wietrzyk
    Academic press:
    ONCOLOGY REPORTS (rok: 2014, tom: 32, strony: 491-504), Wydawca: Spandidos Publications
    Status:
    Published
    DOI:
    10.3892/or.2014.3247 - link to the publication
  1. Tacalcitol (1,24-dihydroxyvitamin D3) enhances 5-fluorouracil activity by suppressing the thymidylate synthase expression in the colon cancer cells HT-29
    Authors:
    M. Milczarek, D. Kłopotowska, A. Kutner and J. Wietrzyk
    Conference:
    The Tenth Multidisciplinary Conference on Drug Research (rok: 2016, ), Wydawca: Pharmaceutical Research Institute
    Data:
    konferencja 15-19 May 2016
    Status:
    Published
  2. Vitamin D analogs re-sensitize 5-FU-resistant HT-29 colon cancer cells to this anticancer drug
    Authors:
    M. Milczarek, M. Starostecka, A. Pawlik, A. Anisiewicz, A. Kutner and J. Wietrzyk
    Conference:
    19th Workshop on Vitamin D (rok: 2016, ), Wydawca: Organizers of Vitamin D Workshop
    Data:
    konferencja 29-31 March 2016
    Status:
    Published